Pfizer, BioNTech to supply Canada with COVID-19 vaccine

Henrietta Brewer
August 6, 2020

After a company pronounces a vaccine safe and effective, Health Canada must approve it for use here before it can be used. The companies are hoping to begin the regulatory review process as early as October and are aiming to provide up to 100 million doses of the vaccine globally by the end of this year and about 1.3 billion doses by the end of 2021.

"These agreements are indicative of our aggressive approach to secure access to vaccine candidates now so that Canadians are at the front of the line when a vaccine becomes available", said Anand.

The New England Journal of Medicine recently published "encouraging" data from Moderna's trials relating to its vaccine candidate, she said. Moderna recently confirmed to Axios that federal money makes up 100 percent of the funding for its COVID-19 vaccine program.

Moderna reported a massive revenue growth in the second quarter, mainly due to its contract with the government to develop a COVID-19 vaccine. President Joko "Jokowi" Widodo said in late July that he expected that next year the Indonesian economy would be able to recover and that a vaccine would be discovered and mass vaccination for "all the people in the country" would be rolled out.

Both Pfizer and Moderna are part of the US government's Operation Warp Speed program to facilitate the development and production of COVID-19 vaccines quickly.

Pfizer said July 22 that it has a US$1.95-billion agreement to supply 100 million doses to the USA government, with an option for 500 million more. Novavax and Pfizer have also had promising vaccine results so far.

"Phase 3 means this is the first time this vaccine has been put into the general population, into otherwise healthy individuals, to see if the vaccine will protect them against natural infection". Bains announced a $56-million contribution to Variation Biotechnologies support clinical trials of its vaccine candidate.

On Tuesday, Canada's chief public health officer, Theresa Tam, warned that a vaccine will be a "very important aspect of the response", but will not bring a swift end to the coronavirus outbreak.

Other reports by iNewsToday